Literature DB >> 8444042

Proline-dependent structural and biological properties of peptides and proteins.

A Yaron1, F Naider.   

Abstract

Proline residues confer unique structural constraints on peptide chains and markedly influence the susceptibility of proximal peptide bonds to protease activity. This review presents a critical analysis of peptidases involved in the cleavage of proline-containing peptide bonds, with particular attention to the role of proline peptidases in the regulation of the lifetime of biologically active peptides. Peptidases discussed include aminopeptidase P, prolidase, dipeptidyl peptidase IV, prolyl endopeptidase, and prolyl iminopeptidase. Attention is also given to HIV-1 protease, because this key enzyme processes an Xaa-Pro peptide bond. Analysis of the above enzymes reveals that they may function as key pacemakers in the control of the activity of many peptide hormones and that they are involved in a variety of immunological processes, including T-cell-mediated immune response. The novel occurrence of cis-trans isomerization about Xaa-Pro bonds and the biological function of peptidyl-prolyl cis-trans isomerases (immunophilins) are reviewed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444042     DOI: 10.3109/10409239309082572

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  70 in total

1.  Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase.

Authors:  M Hegen; J Kameoka; R P Dong; S F Schlossman; C Morimoto
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Porcine CSRP3: polymorphism and association analyses with meat quality traits and comparative analyses with CSRP1 and CSRP2.

Authors:  Xuewen Xu; Haifang Qiu; Zhi-Qiang Du; Bin Fan; Max F Rothschild; Fan Yuan; Bang Liu
Journal:  Mol Biol Rep       Date:  2009-07-26       Impact factor: 2.316

3.  Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.

Authors:  D Reinhold; U Bank; F Bühling; U Lendeckel; J Faust; K Neubert; S Ansorge
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Dissemination of 6S RNA among bacteria.

Authors:  Stefanie Wehner; Katrin Damm; Roland K Hartmann; Manja Marz
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

5.  Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis.

Authors:  Mehmet Horoz; Mehmet Aslan; Fusun F Bolukbas; Cengiz Bolukbas; Yasar Nazligul; Hakim Celik; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

6.  Rapid purification of proline-specific endopeptidase fromFlavobacterium meningosepticum heterologously expressed inEscherichia coli.

Authors:  T Diefenthal; H Dargatz
Journal:  World J Microbiol Biotechnol       Date:  1995-03       Impact factor: 3.312

7.  Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.

Authors:  J Lin; P J Toscano; J T Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Prolidase activity and oxidative status in patients with thalassemia major.

Authors:  Alpay Cakmak; Murat Soker; Ahmet Koc; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

9.  DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.

Authors:  Mariana Rodrigues Davanso; Carolina Caliari-Oliveira; Carlos Eduardo Barra Couri; Dimas Tadeu Covas; Angela Merice de Oliveira Leal; Júlio César Voltarelli; Kelen Cristina Ribeiro Malmegrim; Juliana Navarro Ueda Yaochite
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

10.  Proline iminopeptidase from the outer cell envelope of the human oral spirochete Treponema denticola ATCC 35405.

Authors:  K K Mäkinen; C Y Chen; P L Mäkinen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.